Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Hemoglobin A1c (HbA1c) Testing Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The hemoglobin a1c (hba1c) testing market has experienced substantial expansion in recent years. It is projected to increase from $2.02 billion in 2025 to $2.24 billion in 2026, growing at a compound annual growth rate (CAGR) of 10.5%. The historical development of this market can be attributed to several factors, including the rising global prevalence of diabetes, the increased application of long-term glucose monitoring, the expansion of diagnostic laboratory infrastructure, growing awareness concerning diabetes screening, and the broader adoption of hba1c as a diagnostic standard.
The hemoglobin a1c (hba1c) testing market size is anticipated to experience swift expansion over the coming years. It is projected to reach $3.31 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.3%. This projected growth throughout the forecast period can be attributed to factors such as the increasing uptake of home-based diabetes monitoring, rising investments in connected diagnostic devices, the expansion of preventive healthcare initiatives, a growing emphasis on early diabetes detection, and an increasing demand for rapid diagnostic solutions. Significant trends emerging during this period include the wider adoption of point-of-care hba1c testing devices, a rising need for portable and home-use hba1c analyzers, the expanding integration of wireless and connected testing solutions, the proliferation of high-accuracy laboratory-based hba1c technologies, and an enhanced focus on standardization and diagnostic accuracy.
Get A Free Sample Report With In-Depth Market Insights:
Hemoglobin A1c (HbA1c) Testing Market Growth Catalysts And Demand Drivers
The growing incidence of diabetes is anticipated to stimulate the expansion of the hemoglobin A1c (HbA1c) testing market in the future. Diabetes is a chronic medical condition characterized by the body’s inability to adequately regulate blood glucose levels, stemming from insufficient insulin production or resistance. The surge in diabetes cases is primarily attributed to poor dietary habits, notably high consumption of processed foods and sugary drinks, coupled with sedentary lifestyles. Additionally, the increasing elderly population and a family history of diabetes heighten the risk of developing the condition. HbA1c testing serves to track long-term blood glucose management in diabetic individuals by measuring the average blood sugar over the previous 2–3 months. For example, data released by The Lancet in June 2023 projected that global diabetes cases would climb from 529 million in 2021 to 1.3 billion by 2050. Hence, the rising prevalence of diabetes will be a key driver for the growth of the hemoglobin A1c (HbA1c) testing market.
Hemoglobin A1c (HbA1c) Testing Market Segment Landscape And Growth Outlook
The hemoglobin a1c (hba1c) testing market covered in this report is segmented –
1) By Testing Method: Laboratory-Based Testing, Point Of Care (PoC) Testing
2) By Product Type: Instruments, Reagents, Kits
3) By Technology: Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High Performance Liquid Chromatography
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Homecare Settings
Subsegments:
1) By Laboratory-Based Testing: High-Performance Liquid Chromatography (HPLC) Testing, Ion-Exchange Chromatography, Capillary Electrophoresis
2) By Point Of Care (PoC) Testing: Fingerstick Testing Devices, Portable Hba1c Analyzers, Handheld Hba1c Test Kits
Hemoglobin A1c (HbA1c) Testing Market Industry Trends: What’s Reshaping Demand?
Leading firms operating within the hemoglobin A1c (HbA1c) testing market are emphasizing innovative technologies in diagnostic screening, particularly HbA1c home tests, to provide solutions that are more convenient, precise, and readily available for the early detection and management of diabetes. HbA1c home tests are defined as self-administered diagnostic kits that enable people to assess their average blood sugar levels from the previous 2-3 months, assisting in the surveillance and control of diabetes. An example is Hurdle Health, a US-based company dedicated to delivering innovative healthcare solutions, including diagnostic tools for chronic disease management, which introduced the Hemoglobin A1c (HbA1c) Test in February 2023. This new at-home blood sample examination permits adults to check for and keep track of diabetes, supporting Chronomics’ objective to increase access to diagnostic screening and betterment of health results through direct-to-consumer options.
Hemoglobin A1c (HbA1c) Testing Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the hemoglobin a1c (hba1c) testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH
View The Full Hemoglobin A1c (HbA1c) Testing Market Report:
Hemoglobin A1c (HbA1c) Testing Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin a1c (hba1c) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
